First Time Loading...

Centogene NV
NASDAQ:CNTG

Watchlist Manager
Centogene NV Logo
Centogene NV
NASDAQ:CNTG
Watchlist
Price: 0.4889 USD 1.88% Market Closed
Updated: Apr 29, 2024

Centogene NV
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centogene NV
Operating Income Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Centogene NV
NASDAQ:CNTG
Operating Income
-€35.9m
CAGR 3-Years
-26%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Operating Income
€908m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Income
-€232.9m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Income
-€101.7m
CAGR 3-Years
-13%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€120.3m
CAGR 3-Years
N/A
CAGR 5-Years
57%
CAGR 10-Years
8%
Formycon AG
XETRA:FYB
Operating Income
-€17.7m
CAGR 3-Years
-100%
CAGR 5-Years
-64%
CAGR 10-Years
N/A

See Also

What is Centogene NV's Operating Income?
Operating Income
-35.9m EUR

Based on the financial report for Dec 31, 2022, Centogene NV's Operating Income amounts to -35.9m EUR.

What is Centogene NV's Operating Income growth rate?
Operating Income CAGR 5Y
-51%

Over the last year, the Operating Income growth was 34%. The average annual Operating Income growth rates for Centogene NV have been -26% over the past three years , -51% over the past five years .